Analytical Data
-
Gene name
MAPKAPK2
- Application
-
Alternative Names
MAPKAPK2；MAP kinase-activated Protein kinase 2
-
Species
Human
-
Source
E. coli
-
Tag
His tag N-Terminus
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
P49137
-
Expression Region
1-400aa
-
AA Sequence
MLSNSQGQSP PVPFPAPAPP PQPPTPALPH PPAQPPPPPP QQFPQFHVKS GLQIKKNAII DDYKVTSQVL GLGINGKVLQ IFNKRTQEKF ALKMLQDCPK ARREVELHWR ASQCPHIVRI VDVYENLYAG RKCLLIVMEC LDGGELFSRI QDRGDQAFTE REASEIMKSI GEAIQYLHSI NIAHRDVKPE NLLYTSKRPN AILKLTDFGF AKETTSHNSL TTPCYTPYYV APEVLGPEKY DKSCDMWSLG VIMYILLCGY PPFYSNHGLA ISPGMKTRIR MGQYEFPNPE WSEVSEEVKM LIRNLLKTEP TQRMTITEFM NHPWIMQSTK VPQTPLHTSR VLKEDKERWE DVKEEMTSAL ATMRVDYEQI KIKKIEDASN PLLLKRRKKA RALEAAALAH
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
MAPKAPK2 (Mitogen-Activated Protein Kinase-Activated Protein Kinase 2) is a serine/threonine kinase that plays a crucial role in various cellular processes, including cell proliferation, differentiation, and response to stress signals. It is part of the MAPK (Mitogen-Activated Protein Kinase) signaling pathway, which is activated by various extracellular stimuli and regulates cellular responses to environmental changes. The interest in MAPKAPK2 has grown due to its involvement in critical physiological functions and its implications in various diseases, including cancer, neurodegenerative disorders, and metabolic syndrome. Researchers focus on the recombinant protein of MAPKAPK2 to better understand its structure, function, and regulatory mechanisms. Characterizing the recombinant form allows for detailed analysis of its enzymatic activity, interaction with substrates, and post-translational modifications. Furthermore, studying MAPKAPK2 may reveal potential therapeutic targets and strategies for modulating its activity in disease contexts. As a result, MAPKAPK2 recombinant protein research not only enhances our understanding of fundamental biological processes but also opens avenues for the development of novel therapeutic interventions.
